TECELRA
NDC 83205-0001, afamitresgene autoleucel, injection, suspension, from USWM CT, LLC.
- Product NDC
- 83205-0001
- Status
- Listed
- Labeler
- USWM CT, LLC
- Dosage form
- INJECTION, SUSPENSION
- Route
- INTRAVENOUS
- Product type
- CELLULAR THERAPY
- Marketing category
- BLA
- Application
- BLA125789
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83205-0001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- AFAMITRESGENE AUTOLEUCEL10000000000 1/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83205-0001-2 | 83205000102 | 1 INJECTION, SUSPENSION in 1 BAG (83205-0001-2) |
Linked data
RxNorm, label and prices
Related lookups
Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=83205-0001
Use it
Look up 83205-0001 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83205-0001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83205-0001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.